Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript February 22, 2024 Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome […]
City Office REIT, Inc. (NYSE:CIO) Q4 2023 Earnings Call Transcript February 22, 2024 City Office REIT, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $0.33. City Office REIT, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
Celanese Corporation (NYSE:CE) Q4 2023 Earnings Call Transcript February 21, 2024 Celanese Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Celanese Q4 2023 Earnings Call and Webcast. [Operator Instructions]. As a reminder, this conference […]
Medallion Financial Corp. (NASDAQ:MFIN) Q4 2023 Earnings Call Transcript February 21, 2024 Medallion Financial Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome to the Medallion Financial Corporation Fourth Quarter and Full Year 2023 Earnings Conference […]